Extracorporeal respiratory support in patients with acute respiratory distress syndrome is applied either as rescue maneuver for life-threatening hypoxemia or as a tool to reduce the harm of mechanical ventilation. Depending on the blood and gas flow, extracorporeal support may completely substitute the natural lung as a gas exchanger (high-flow venovenous bypass) or reduce the need for mechanical ventilation, enabling the removal of a fraction of the metabolically produced CO 2 .
INTRODUCTION
If you begin to read this article while hoping to find an evidence-based answer on how to set mechanical ventilation during extracorporeal membrane lung oxygenation (ECMO) in patients with the acute respiratory distress syndrome (ARDS), we suggest you stop reading here. Such an answer does not exist, as shown also by the most recent literature [1 & ,2,3]. However, physiology, previous experiences and experimental data do exist and may help to design a reasonable scenario in which the lung treatment during extracorporeal support should or could be discussed. Saying so, what we will discuss here is matter of opinion and we represent ours.
Respiratory support does not cure the lung but buys time for the lung to heal. Ideally, it should do so without adding per se any harm to the respiratory system. In reality, it carries harms, which increase with the extent of the mechanical power delivered by the ventilator and with the decrease of the lung's size and homogeneity [4] . In contrast, instead of substituting the respiratory muscles function, the extracorporeal support substitutes the alveolar capillary function, allowing a viable gas exchange through the artificial lung. Its harm is primarily related to the risk of hemorrhage due to the anticoagulation needed. Therefore, the clinical challenge, if the two techniques are combined, is to tailor them in a way to reduce their specific risks to a minimum. The worst that can be done is to combine them in such a way that their harms instead of their benefits are added up.
TEXT OF THE REVIEW
As shown in Fig. 1 , we may conceptually look at an ARDS lung as a composition of three compartments, which usually follow a topographical distribution. In the nondependent regions, we may include the part of the lung in which the alveoli are overdistended [high ventilation/perfusion (VA/Q) ratio] and normodistended (normal VA/Q ratio). In the middle part, the alveoli with normal VA/Q may coexist with a progressive increase of alveoli characterized by a VA/Q lower than normal. The more dependent regions of the lung consist usually of alveoli that are compressed (i.e. recruitable to aeration with adequate pressure) together with the alveoli that are consolidated (i.e. unrecruitable at whatever pressure applied). This region is characterized by a VA/Q ratio equal to 0 (i.e. shunt). Regarding perfusion, the ARDS lung is characterized by a generalized vasoconstriction, associated with presence of microthrombi and capillary collapse, primarily in the most dependent regions. The hypoxic vasoconstriction, primarily due to a low mixed venous oxygen partial pressure dictates a lower perfusion in the poorly/nonaerated regions. Consequently, in ARDS, a similar amount of physiological shunt may be associated with 20-40% of nonaerated lung tissue [5] . The model we described may obviously largely vary between ARDS patients, nevertheless it may represent a useful model for better discussing the relationship between the natural and the artificial lung.
The anatomical-physiological background dictates the characteristics of gas exchange during ARDS, which, in absence of extracorporeal support, may be summarized as follows:
KEY POINTS
Extracorporeal support in ARDS is applied as a rescue maneuver for life-threatening hypoxemia (high-flow VV ECMO) or to reduce the harm of mechanical ventilation (low-flow ECCO 2 R). A representative model of an acute respiratory distress syndrome lung. As shown, the increased lung weight due to the inflammatory edema leads to an increase of the superimposed pressure from sternal to vertebral. Accordingly, the pulmonary units are progressively less aerated, down to collapse (compression and later reabsorption atelectasis). Some units are consolidated instead of collapsed and occupied by pathological material (edema, inflammatory cells, fibrosis etc.). These units are unrecruitable. The independent lung regions are characterized by normal or hyperdistended units, in particular if positive end-expiratory pressure is applied. The ventilation-perfusion ratio follows this anatomical distribution. In general, all the vasculature is constricted, with possible capillary occlusions due to microthrombi or compression.
(1) High dead space, due both to the high VA/Q, typical of the upper lung regions, and to the possible presence of microthrombi in the lung capillaries. (2) Presence of low VA/Q regions [6] , which may account for up to 40% of the venous admixture and may switch to a better gas exchange by increasing positive end-expiratory pressure (PEEP). From this model, it is evident that the correction of hypoxemia, for a given oxygen consumption and a given hemodynamic setting, consists of two steps:
(1) Increasing fraction of inspired oxygen (FiO 2 ) to correct the hypoxemia fraction caused by the low VA/Q regions. (2) Applying a mean airway pressure and PEEP sufficient to keep the collapsed alveoli open (at least part of them) and to improve inflation.
Of note, neither of these two interventions to correct hypoxemia requires per se mechanical ventilation, as they can be applied simply through continuous positive airway pressure or high-flow oxygen [8] , which may guarantee in most cases a lung inflation adequate for the oxygen transfer to occur.
For CO 2 clearance, instead, inflation is not sufficient, as the inflated regions must be ventilated to allow an adequate CO 2 removal. It is crucial to understand the difference between inflation and ventilation. If we maintain, as an example, a constant inflation volume by providing an amount of oxygen equal to the oxygen transferred from the alveoli to the lung capillaries (a process known as apneic oxygenation), the only limit is the progressive rise in partial pressure of CO 2 [9] . If, however, the CO 2 produced metabolically is removed by the artificial lung, the apneic oxygenation may be prolonged indefinitely, providing a total lung rest [10] . Therefore, oxygenation may be achieved through an inflated and totally immobile lung by supplying, through a small catheter, an amount of oxygen equal to the one consumed by the blood flow perfusing the lung. In contrast, the CO 2 clearance requires the ventilation of the lung. In ARDS, due to the high respiratory dead space and to the heavy lung, spontaneous breathing cannot maintain indefinitely the high ventilation required for CO 2 clearance, and mechanical ventilation is needed to substitute the fatigued respiratory muscles. The price of providing the mechanical power [11] required to move the ARDS lungs may be the ventilator-induced lung injury (VILI).
In this scenario, the artificial lung is applied for two main reasons [12] :
(1) As a rescue oxygenation, because of life-threatening hypoxemia (whatever this may mean).
(a) Venovenous bypass ( Fig. 2a) : the extra oxygen added by the artificial lung increases the mixed venous oxygen saturation to an extent that depends on the ratio between the flow to the artificial lung and the cardiac output. Note that the gain in oxygen content on the arterial side is due to an increase in the oxygen content flowing in the shunted areas, whereas the oxygen transfer from the natural lung to the lung capillaries decreases due to decreased gradient between alveolar and mixed venous partial pressure of oxygen. The increase in mixed venous saturation may sharply decrease the hypoxic vasoconstriction (thus increasing the shunt). In case of rescue oxygenation, flows as high as 3-5 l/min are normally used. At this rate, with a sweep gas/blood flow ratio 1 : 1-2 : 1, the membrane lung removes nearly all the metabolically produced CO 2 . (b) Venoarterial bypass ( Fig. 2b) : as shown in the figure, the total amount of oxygen transferred to the arterial side is identical to the one transferred through the V-V bypass for the same artificial lung settings. There are, however, several differences: although the V-V bypass guarantees an even distribution of the oxygen in the arterial side (due to the mixing occurring in the right heart-lungs compartment), the arterial PaO 2 resulting from a V-A bypass depends on the placement of the return cannulas. More importantly, the venous-arterial bypass provides also a circulatory support by substituting (at different extents) the heart's function. This implies severe hypoperfusion of the natural lung. If mechanical ventilation is applied during a V-A bypass, extreme attention must be paid to the possible high VA/Q ratios that experimentally led to massive lung infarction [13] . (2) The second main reason for using a membrane lung is to decrease the need for ventilation by removing the CO 2 through the artificial lung. Doing so, the possible harm of mechanical ventilation may be greatly decreased to an extent proportional to the CO 2 removal, up to 100% by keeping the lung immobile during apneic oxygenation.
In Table 1 , we show how mechanical ventilation is usually applied during ECMO. Data are derived from three recent studies: one multicenter, retrospective trial and two reviews/meta-analyses [1 & ,2,3]. It is worth observing how in these studies no differences were made between V-V and V-A ECMO, nor data as CO 2 -O 2 transfer in the membrane lung, hemodynamic status, the patients' dead space and shunt fraction were reported.
Despite these limitations, Table 1 clearly shows a common trend:
(1) A moderate reduction of FiO 2 (from 0.9 to about 0.7), although in some centers FiO 2 as low as 0.3 was used since the first day on ECMO [14] ; (2) A moderate reduction of tidal volume (by 2 ml/ kg) and driving pressures (these measures are suggestive for the application of 'ultra-protective' ventilation strategies). (3) A moderate reduction of respiratory rate (this measure seems to aim at preventing/limiting a possible hypocapnia). (4) A maintenance of constant PEEP or its slight reduction (a reaction, we suppose, to the increased P/F).
These changes were associated with a consistent decrease in respiratory system compliance, an increase in PaO 2 /FiO 2 ratio and an increase of estimated right-to-left shunt.
The data suggest that all the potential of highflow ECMO (i.e. to provide full gas exchange) is not exploited in the usual clinical practice. In fact, mechanical ventilation is only slightly modified and appears substantially the same during high-flow V-V ECMO in severe ARDS or low-flow extracorporeal CO 2 removal (ECCO 2 R) in moderate ARDS [15 && ]. Each of the mechanical ventilation components could be modified at far larger extent when ECMO is applied.
Likely, the FiO 2 ventilating the natural lung may be decreased to far lower levels than actually generally used (only one center was using a FiO 2 of 0.3 after 24 h) [14] . We may use a recently described accurate mathematical model to simulate the patient-ECMO interaction [16] . Let's consider a patient similar to an 'average' patient described in Table 1 , during the first 24 h on ECMO. The membrane lung is ventilated with 100% oxygen and is perfused with a blood flow of 4.5 l/min. Assuming a patient's oxygen consumption of 260 ml/min, 10 g/ dl of hemoglobin and 0.7 FiO 2 in the membrane lung, the computed shunt is 75%, the PaO 2 is 95 mmHg and the arterial oxygen saturation (Sat a O 2 ) is 96%. Decreasing the FiO 2 in the natural lung to 0.5 will lead to a PaO 2 of 83 mmHg and a FIGURE 2. In panel (a), we represent a V-V extracorporeal membrane lung oxygenation in which the artificial lung is in series with the natural lung. As shown, the oxygen added to the artificial lung increases the saturation of the blood in the pulmonary artery. Accordingly, the O 2 transfer from the natural lung decreases, whereas the oxygen content of the blood flowing through the shunt area increases. The equation below shows the arterial oxygen as a function of the capillary content of oxygen, the shunt fraction (Qs/Qt) and the extracorporeal blood flow. VO 2 represents the oxygen consumption, whereas the CvO 2 represents the oxygen content in the venous blood. In this model, the capillary content of oxygen in the natural lung is considered equal to the capillary content of oxygen of the membrane lung. The equation assumes that only one variable may be changed at a time. In reality, the increase of oxygen saturation in the blood reaching the natural lung increases the Qs/Qt due to the loss of hypoxic vasoconstriction. In panel (b), we represent a V-A extracorporeal membrane lung oxygenation. Symbols as in panel (a). The equation estimating the effect of extracorporeal blood flow on arterial oxygenation ends up to be equal to the one presented in panel (a). All the equations are based on Fick's principle.
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Sat a O 2 of 95%. If the FiO 2 in the membrane lung is decreased to the same level of FiO 2 of the natural lung (i.e. 0.5), the resulting PaO 2 should be 62 mmHg (Sat a O 2 90%). However, if the decrease of FiO 2 in the membrane lung is associated with an increase of hypoxic vasoconstriction with a shunt fraction reduction to 43% (the same shunt this hypothetical patient had before ECMO), the PaO 2 should rise to 105 mmHg (Sat a O 2 96%). These data strongly suggest that there is a large space for FiO 2 reduction during ECMO. The decreased FiO 2 in the natural lung is associated theoretically with several advantages:
(1) Decrease of one potential contributor to VILI. It is worth remembering that the first randomized clinical trial on ECMO (V-A mode) was designed just to decrease the FiO 2 in the treated groups [17] . (2) Increase of nitrogen concentration in the alveolar compartment with associated better stability of instable alveoli and decreased likelihood of reabsorption atelectasis [18] . (3) Equalizing the FiO 2 in the membrane lung to the one in the natural lung prevents the possibility of reabsorption atelectasis (due to different partial pressures of nitrogen between the alveolar and capillary side) without substantially affecting the oxygen transport [10] .
Therefore, considering all aspects mentioned above, similar FiO 2 in natural and membrane lung at the lowest level compatible with arterial saturation greater than 90% could be of theoretical advantage compared with the usual practice of setting FiO 2 at 1.0 in the membrane lung. By the way, high FiO 2 during ECMO has been found to be independently associated with a worse outcome [3] .
The reduction of tidal volume and driving pressure, the bedrocks of lung protective strategies, largely used in ARDS patients without ECMO, are further enhanced during ECMO treatment. However, an excessive tidal volume reduction implies possible risks:
(1) The 'ultra-protective' strategy [15 && ] (i.e. severe hypoventilation with normocapnia) may be associated, due to the absorption atelectasis, to a life-threatening hypoxemia during lowflow ECCO 2 R, as the extracorporeal support does not provide sufficient oxygen [19 The PEEP level is crucial in maintaining lung volume when respiratory rate and/or tidal volume are decreased, either in spontaneous breathing or in mechanical ventilation. In fact, it is worth reminding that in healthy animals a complete apneic oxygenation is associated with a 50% decrease in functional residual capacity in 24 h [10] ; to maintain static lung volumes without any ventilation, PEEP greater than 20 cmH 2 O is mandatory; to maintain the lung volume at lower PEEP levels, at least 2 bpm at a plateau pressure of 25-30 cmH 2 O is necessary [20] . Low-frequency ventilation (4 bpm), associated with apneic oxygenation during ECCO 2 R, was introduced to maintain lung volume, not to contribute to CO 2 clearance [21] . As shown in Table 1 , the mechanical ventilation usually applied in clinical settings is associated with a decrease in compliance, which in turn suggests a lung collapse occurrence, likely due to a reduction in mean airway pressure, without PEEP compensation. Obviously, despite a possible increasing in atelectasis, the high ECMO flows maintain adequate oxygenation. However, this can be associated with occurrence/ worsening of pulmonary hypertension with consequent right heart failure and increased need for shifting from V-V to V-A ECMO, as anecdotally reported [22] .
CONCLUSION
Extracorporeal support is a powerful tool able to provide the complete spectrum of respiratory support, from total gas exchange (O 2 and CO 2 ) down to partial CO 2 removal. However, it appears that, independently of the extent and the modality of the extracorporeal support used, the ventilatory strategy applied is the same, that is a lung protective strategy (as in ARDS patients without ECMO) consisting in a slight reduction of tidal volume and FiO 2 while keeping the PEEP constant. If these are the targets of the mechanical treatment of the lung, the high-flow ECMO appears out of proportion. Therefore, either the target or the ECMO should be revised. Otherwise, the risk is just to unnecessarily add the ECMO complications to the risks of mechanical ventilation. In Table 2 , we show, in a representative ARDS patient, the mechanical power associated with mechanical ventilation: without ECMO; with high-flow ECMO, as currently applied; as suggested by the Extracorporeal Life Support Organization [23] and as theoretically possible. Clearly, the aim should be to find which one of these (or other) provides the best conditions for the lungs to heal: whichever it is, ECMO opens the space to apply it.
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